Mason Street Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-19,646
| Closed | -$494K | – | 1111 |
|
|
2020
Q4 | $494K | Sell |
19,646
-112
| -0.6% | -$2.82K | 0.01% | 1174 |
|
|
2020
Q3 | $412K | Buy |
19,758
+33
| +0.2% | +$688 | 0.01% | 1148 |
|
|
2020
Q2 | $468K | Buy |
19,725
+1,452
| +8% | +$34.5K | 0.01% | 1106 |
|
|
2020
Q1 | $329K | Hold |
18,273
| – | – | 0.01% | 1130 |
|
|
2019
Q4 | $433K | Buy |
18,273
+464
| +3% | +$11K | 0.01% | 1182 |
|
|
2019
Q3 | $489K | Buy |
17,809
+323
| +2% | +$8.87K | 0.01% | 1108 |
|
|
2019
Q2 | $579K | Buy |
17,486
+683
| +4% | +$22.6K | 0.01% | 1044 |
|
|
2019
Q1 | $589K | Buy |
16,803
+575
| +4% | +$20.2K | 0.01% | 1080 |
|
|
2018
Q4 | $539K | Buy |
16,228
+757
| +5% | +$25.1K | 0.01% | 1013 |
|
|
2018
Q3 | $779K | Buy |
15,471
+514
| +3% | +$25.9K | 0.02% | 960 |
|
|
2018
Q2 | $895K | Buy |
14,957
+660
| +5% | +$39.5K | 0.02% | 902 |
|
|
2018
Q1 | $655K | Buy |
14,297
+964
| +7% | +$44.2K | 0.02% | 956 |
|
|
2017
Q4 | $531K | Buy |
13,333
+493
| +4% | +$19.6K | 0.01% | 1008 |
|
|
2017
Q3 | $514K | Buy |
12,840
+440
| +4% | +$17.6K | 0.01% | 1009 |
|
|
2017
Q2 | $534K | Buy |
12,400
+680
| +6% | +$29.3K | 0.01% | 982 |
|
|
2017
Q1 | $367K | Buy |
11,720
+902
| +8% | +$28.2K | 0.01% | 1071 |
|
|
2016
Q4 | $273K | Buy |
10,818
+626
| +6% | +$15.8K | 0.01% | 1145 |
|
|
2016
Q3 | $252K | Buy |
10,192
+3,429
| +51% | +$84.8K | 0.01% | 1129 |
|
|
2016
Q2 | $138K | Buy |
6,763
+675
| +11% | +$13.8K | ﹤0.01% | 1294 |
|
|
2016
Q1 | $93K | Buy |
6,088
+568
| +10% | +$8.68K | ﹤0.01% | 1357 |
|
|
2015
Q4 | $74K | Buy |
5,520
+524
| +10% | +$7.03K | ﹤0.01% | 1379 |
|
|
2015
Q3 | $70K | Buy |
4,996
+1,037
| +26% | +$14.5K | ﹤0.01% | 1369 |
|
|
2015
Q2 | $67K | Buy |
+3,959
| New | +$67K | ﹤0.01% | 1399 |
|